A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC

Abroad (travel likely)RecruitingPHASE1

Conditions

Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Bilal Siddiqui, MD) · basiddiqui@mdanderson.org · 713-563-4600
Contact: Principal Investigator (Bilal Siddiqui, MD)

Study leads

Bilal Siddiqui, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Metastatic Castration Resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia · Sydney, Australia

Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe

Prostate Cancer (Diagnosis)

Abroad (travel likely)RecruitingPHASE1

Baltimore, United States

A Study of NX-1607 in Adults With Advanced Malignancies

Ovarian Cancer, Epithelial · Gastric Cancer · GastroEsophageal Junction (GEJ) Cancer

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Los Angeles, United States

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Advanced Solid Cancer · Metastatic Solid Tumor · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Zhengzhou, China · Shanghai, China